CORCEPT THERAPEUTICS. Closed position at $4.86 for a 65% GAIN.

* View the covered positions for the Newsletter Portfolio.
70% have been for GAINS of 50% or GREATER.

The Newsletter is published twice-monthly. Upon receipt of your subscription, we will e-mail a password, and further information, to you. Good Luck.

Rated a STRONG BUY or BUY by five analysts, this genomics company just signed a sequencing deal with the Mayo Clinic; trading at near its 52-week low.

Two analysts rate this drug maker a STRONG BUY as it develops products aimed at obesity and it recently raised $86 million to help in its endeavors; trading at around $3.00.

* Subscribers may now login to view the current newsletter.

* Not a subscriber? SUBSCRIBE TODAY!

DRY SHIPS, INC. Closed position at $3.78 for a 77% GAIN.

BIOCRYST PHARMACEUTICALS. Closed position at $4.26 for a 55% GAIN.

HOLLYWOOD MEDIA. Closed position at $1.26 for a 53% LOSS.

* View the covered positions for the Newsletter Portfolio.
70% have been for GAINS of 50% or GREATER.

The Newsletter is published twice-monthly. Upon receipt of your subscription, we will e-mail a password, and further information, to you. Good Luck.

Rated a BUY by three analysts this biotech is developing treatments for a variety of cancers; trading at near its twelve-month low of $2.00.

TEN ANALYSTS are following this software developer for mobile devices as it seems to be making a turnaround; trading at under $2.00.

* Subscribers may now login to view the current newsletter.

* Not a subscriber? SUBSCRIBE TODAY!

NAUTILUS, INC. Closed position at $2.53 for a 51% GAIN.

* View the covered positions for the Newsletter Portfolio.
70% have been for GAINS of 50% or GREATER.

The Newsletter is published twice-monthly. Upon receipt of your subscription, we will e-mail a password, and further information, to you. Good Luck.

CELLDEX THERAPEUTICS. Closed position at $4.53 for a 68% GAIN.

TRANS1, INC. Closed position at $2.93 for a 57% GAIN.

APPLIED ENERGETICS. Closed position at 10¢ for a 94% LOSS.

* View the covered positions for the Newsletter Portfolio.
70% have been for GAINS of 50% or GREATER.

The Newsletter is published twice-monthly. Upon receipt of your subscription, we will e-mail a password, and further information, to you. Good Luck.

Four analysts are following this diagnostics developer whose technology enables sensitive gnomic and protein testing on a single platform; trading at around $1.50.

Six analysts rate this electronics maker a "STRONG BUY" as it recently announced deals with an electric vehicle company and several power generators; trading near its yearly low of $2.50.

* Subscribers may now login to view the current newsletter.

* Not a subscriber? SUBSCRIBE TODAY!

BIODELIVERY SCIENCES INTL. Closed position at $1.93 for a 105% GAIN.

* View the covered positions for the Newsletter Portfolio.
70% have been for GAINS of 50% or GREATER.

The Newsletter is published twice-monthly. Upon receipt of your subscription, we will e-mail a password, and further information, to you. Good Luck.

This biotech, rated a STRONG BUY by four analysts and a BUY by three others, is developing gamma detection technology to uncover undetected disease; trading at around $2.50.

Four analysts rate this healthcare provider a STRONG BUY or a BUY as it moves to expand its market for degenerative disc treatment; trading at under $2.00.

* Subscribers may now login to view the current newsletter.

* Not a subscriber? SUBSCRIBE TODAY!

FSI INTERNATIONAL. Closed position at $3.74 for a 54% GAIN.

* View the covered positions for the Newsletter Portfolio.
70% have been for GAINS of 50% or GREATER.

The Newsletter is published twice-monthly. Upon receipt of your subscription, we will e-mail a password, and further information, to you. Good Luck.